VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2020 | Novel approaches for MPNs

Ruben Mesa, MD, of UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, describes novel developments in the treatment of myloproliferative neoplasms (MPNs) including the development of IMG-7289 for essential thrombocythemia (ET) and myelofibrosis as well as studies evaluating ropeginterferon alfa-2b for both ET and polycythemia vera. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter